celastrol has been researched along with docetaxel anhydrous in 2 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 12,110 | 3,216 | 6,920 |
| Protein | Taxonomy | celastrol (IC50) | docetaxel anhydrous (IC50) |
|---|---|---|---|
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Elwakil, MM; Abdelmoneem, MA; Abdulkader, MA; Albericio, F; Bekhit, AA; Elkhodairy, KA; Elzoghby, AO; Helmy, MW; Khattab, SN; Teleb, M; Zaky, A | 1 |
| Fan, M; Huang, G; Liu, Z; Ma, L; Xia, C; Xuan, X | 1 |
2 other study(ies) available for celastrol and docetaxel anhydrous
| Article | Year |
|---|---|
Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Delivery Systems; Humans; Lactoferrin; Mice; Nanoconjugates; Nanoparticles; NF-kappa B; Pentacyclic Triterpenes | 2021 |
Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cells.
Topics: Cadherins; Cell Line, Tumor; Docetaxel; Humans; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms | 2022 |